This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Globus Medical (GMED) Lags Q4 Earnings, Beats on Revenues
by Zacks Equity Research
Globus Medical (GMED) registers impressive growth within U.S. Spine on record recruiting of competitive representatives in Q4.
NuVasive (NUVA) Earnings and Revenues Beat Estimates in Q4
by Zacks Equity Research
NuVasive's (NUVA) Biologics business returns to growth in the fourth quarter of 2019.
Add These 5 GARP Stocks to Your Portfolio for Maximum Returns
by Zacks Equity Research
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
Bruker (BRKR) Stock Rises on Strong Preliminary Q4 Show
by Zacks Equity Research
Bruker's (BRKR) revenue growth is expected to beat expectations for the fourth quarter and 2019.
Henry Schein Stock Hits New 52-Week High: What's Driving It?
by Zacks Equity Research
Henry Schein (HSIC) is optimistic about maintaining growth momentum on several recent developments.
Chemed (CHE) Q4 Earnings & Revenues Beat Estimates, Margins Up
by Zacks Equity Research
Chemed's (CHE) fourth-quarter 2019 results reflect strong segmental performances.
Tandem Diabetes Hits New 52-Week High: What's Driving It?
by Zacks Equity Research
Tandem Diabetes (TNDM) is optimistic about maintaining growth momentum on several recent developments.
The Zacks Analyst Blog Highlights: ResMed, Ensign, DaVita, KalVista Pharmaceuticals and MEI Pharma
by Zacks Equity Research
The Zacks Analyst Blog Highlights: ResMed, Ensign, DaVita, KalVista Pharmaceuticals and MEI Pharma
Here's Why You Should Retain Haemonetics in Your Portfolio Now
by Zacks Equity Research
Haemonetics (HAE) witnesses high investor confidence on solid prospects.
Cardiovascular Systems Grows on Domestic Sales Amid Margin Woe
by Zacks Equity Research
Cardiovascular Systems (CSII) continues to register solid top-line growth on strength in the domestic atherectomy businesses.
Teleflex COMFORT FLO System's Voluntary Recall Ranked Class I
by Zacks Equity Research
Teleflex's (TFX) COMFORT FLO Humidification System up for worldwide voluntary recall after the receipt of complaints of device malfunction.
Medtronic Buys Digital Surgery, Boosts AI-Focus Surgical Care
by Zacks Equity Research
Medtronic (MDT) to integrate Digital Surgery's business within its Surgical Robotics arm, in turn augmenting the company's position in the field of surgical AI.
Myriad Genetics (MYGN) Releases Favorable Prolaris Results
by Zacks Equity Research
This study result is a major breakthrough and is expected to strengthen Myriad Genetics' (MYGN) Oncology segment.
Bio-Rad (BIO) Q4 Earnings & Revenues Fall Short of Estimates
by Zacks Equity Research
Bio-Rad's (BIO) fourth-quarter 2019 results reflect strong segmental performances.
Walgreens U.S. Retail Pharmacy Rises Amid Reimbursement Woes
by Zacks Equity Research
Intensifying competition in the U.S. retail drugstore market prompts Walgreens Boots (WBA) to diversify its product offerings.
Myriad Genetics (MYGN) Files for myChoice CDx Test sPMA
by Zacks Equity Research
With the receipt of the regulatory approval, Myriad Genetics (MYGN) will be taking a major stride forward in its Oncology and Women's Health segment.
New Covid-19 Cases Increase, 5 Defensive Stocks to Buy
by Zacks Equity Research
Here are five defensive stocks that can shield your portfolio as Covid-19 continues to spread, instilling volatility in the stock market.
Omnicell-Geisinger Deal Improves Patient Care via Automation
by Zacks Equity Research
Omnicell's (OMCL) XT series Automated Dispensing Systems partners with Geisinger to streamline nursing workflow and improve patient care.
CVS Health (CVS) Q4 Earnings Top Estimates, Margins Improve
by Zacks Equity Research
CVS Health (CVS) registers strong growth in Pharmacy Services, benefiting from the upside in specialty services.
Zacks.com featured highlights include: Chipotle Mexican Grill, Vertex Pharmaceuticals, ResMed, Spirit Airlines and OneMain
by Zacks Equity Research
Zacks.com featured highlights include: Chipotle Mexican Grill, Vertex Pharmaceuticals, ResMed, Spirit Airlines and OneMain
Exact Sciences (EXAS) Q4 Earnings and Revenues Rise Y/Y
by Zacks Equity Research
Exact Sciences' (EXAS) fourth-quarter 2019 results reflect strong segmental performances.
LabCorp (LH) Rides on Solid Diagnostics Despite PAMA Issues
by Zacks Equity Research
LabCorp's (LH) Covance Drug Development delivers organic growth despite foreign currency headwind.
Here's Why You Should Add Hill-Rom to Your Portfolio Now
by Zacks Equity Research
Investor confidence is at a high, thanks to Hill-Rom (HRC) solid prospects.
STERIS (STE) Surpasses Q3 Earnings Estimates, Ups FY20 View
by Zacks Equity Research
STERIS' (STE) third-quarter fiscal 2020 results reflect strong segmental performances.
Buy These 5 Stocks With Attractive Sales Growth Right Now
by Swayta Shah
Sales growth is an important metric for any company, as it is a vital part of growth projections and instrumental in strategic decision making.